Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01251757 · ClinicalTrials.gov registry record · NA

Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
21,752
Enrollment target

NCT01251757: Completed NA study, sponsored by Kaiser Permanente.

NCT01251757 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 21,752 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1450% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01251757, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
21,752 participants
Enrollment target

Study Summary

The purpose of this randomized clinical trial is to determine whether two low-intensity, technology based interventions, when compared to each other and to usual care, improve adherence to selected medications that are used to treat people with cardiovascular disease (CVD) and diabetes.

Primary Outcome

We used a modification of the Medication Possession Ratio (MPR) as our primary outcome measure. The MPR is computed as the number of days' supply of medication dispensed during a given time window divided by the time between the first dispensing in the window and the end of the window. Our modified MPR (mMPR) also accounted for medication that was on hand at the start of the window and ignored any days' supply that would extend beyond the end of the window. We used medication dispensing data fr

Interventions

  • OTHER Interactive Voice Recognition (IVR) phone calls
  • OTHER Educational mailings and follow-up for nonadherence

Trial Details

FieldValue
Enrollment Target 21,752 participants
Start Date 2011-08
Est. Completion 2013-08
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT01251757 record still lists

NCT01251757 is an interventional study that assigns participants to a tested intervention. Its 21,752 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1450% higher).

The record links to 0 conditions, and to 2 interventions - of which Interactive Voice Recognition (IVR) phone calls is the first listed.

NCT01251757 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01251757 about?

NCT01251757 is a clinical study titled "Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies". The purpose of this randomized clinical trial is to determine whether two low-intensity, technology based interventions, when compared to each other and to usual care, improve adherence to selected medications that are used to treat people with cardiovascular disease (CVD) and diabetes.

What is the current status of trial NCT01251757?

This trial is currently completed. It is a NA study. The enrollment target is 21,752 participants. The study started on 2011-08. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01251757?

The interventions under investigation include: Interactive Voice Recognition (IVR) phone calls (OTHER), Educational mailings and follow-up for nonadherence (OTHER).

Who is sponsoring clinical trial NCT01251757?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01251757's enrollment target sits among peer trials

21,752 10th of 2000 higher than 1,991 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05832307 · 22,000 participants · NA

    The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

  • NCT05488080 · 22,032 participants · NA

    PAINED: Project Addressing INequities in the Emergency Department

  • NCT07413211 · 22,068 participants

    Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

  • NCT06047041 · 21,350 participants · NA

    Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01251757, the US trial registry maintained by the National Library of Medicine. NCT01251757 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.